Revised. Amendments from Version 1
==================================

We would like to thank our reviewers for their insightful comments and suggestions that contributed towards an improvement of the manuscript. Specific details of the changes can be found in our response to reviewers. Significant changes include:  1) amendments to the identification system for the patients to reflect the same numbering used in a previously published paper on this group of patients; 2) an added supplementary table (supplementary table 2) to allow for identification of each patient and their corresponding DICOM file; 3) addition of predicted protein effects for each mutation in Table 1; 4) the addition of a quantitative analysis of corpus callosum volume, total white and grey matter volume, and whole brain volume (supplementary table 1 and supplementary figure 1) for aniridia and PAX6-normal comparisons.

Introduction
============

Aniridia is panocular, congenital, and progressive disorder with an occurrence of approximately 1 in 83,000 live births ^[@ref-1],\ [@ref-2]^. Aniridia is best characterized by the lack of or hypoplasia of the iris (for which it is named), in addition to several other ocular abnormalities, which culminate in reduced visual acuity ^[@ref-3]^. Due to the progressive nature of the disease, individuals usually develop multiple ocular abnormalities, such as keratopathy, corneal vascularization and opacification, glaucoma, anterior chamber fibrosis, and cataracts ^[@ref-4]--\ [@ref-7]^. Although aniridia is most well known for its ocular phenotypes, the condition has a number of other abnormalities, including sensory, neural, cognitive, and auditory processing abnormalities ^[@ref-8],\ [@ref-9]^.

The development of aniridia in humans is linked to heterozygous loss-of-function mutations to the *PAX6* gene, which encodes a highly conserved transcription factor critical for normal eye and neural development ^[@ref-1]^. The vast majority of aniridia cases (80%) are associated with mutations in *PAX6* ^[@ref-2],\ [@ref-10]^. Functional mutations in this gene can be either sporadic or familial, and causal mutations in aniridia encompass a large number of variants. The majority of these variants are nonsense mutations, which lead to a premature termination codon, and are found across the *PAX6* locus ^[@ref-10],\ [@ref-11]^. *PAX6* is expressed in the developing eye, brain, and spinal cord, and is required for aspects of anatomical and functional development of the central nervous system (CNS) and visual system ^[@ref-12]^. Within the CNS, *PAX6* is involved in patterning, regionalization, and the formation of neural circuits ^[@ref-13]--\ [@ref-16]^. Previous studies of patients with aniridia using structural magnetic resonance imaging (MRI) have shown abnormalities in major fiber tracts and subcortical structures of the brain, including the anterior commissure ^[@ref-9],\ [@ref-17]--\ [@ref-20]^, posterior commissure ^[@ref-18],\ [@ref-20]^, corpus callosum ^[@ref-9],\ [@ref-19],\ [@ref-20]^, pineal gland ^[@ref-18],\ [@ref-20]^, optic chiasm ^[@ref-20]^, and olfactory bulb ^[@ref-17],\ [@ref-18]^. The most consistently reported abnormalities are found in the anterior commissure, pineal gland, and optic chiasm; abnormalities in the posterior commissure, corpus callosum, and olfactory bulb are found in fewer than 35% of patients examined. Additionally, studies have shown conflicting results regarding grey matter volume differences in aniridia, with reports of both increases and decreases in whole brain grey matter ^[@ref-21],\ [@ref-22]^. Most recently, it has been shown that there is an accelerated age-related increase in cortical thinning of the inferior parietal lobe and prefrontal/premotor areas in both brain hemispheres in aniridia compared to healthy patients ^[@ref-23]^.

While several previous studies have investigated structural brain abnormalities in patients with aniridia, the variance in brain structures affected and extent of anatomical abnormalities is high. The variance observed in the published literature may be interpreted as a result of genetic differences in patient samples, either directly related to disease-causing mutations or modifier effects caused by genomic differences across subjects. Most of the previous studies examining structural changes in the brain of aniridia patients have focused on a subset of the structures we examined, but only one other study has looked at all five together ^[@ref-20]^. Additionally, we used a 3T magnet instead of a 1.5T, which allows for higher resolution structural images of small structures such as interhemispheric commissures, allowing us to more reliably identify subtle difference. The current study sought to investigate gross anatomical correlates of aniridia in a new population sample with varied *PAX6* mutations. Results from this study will serve as a comparison for previous studies, as well as contribute to what is known about the distribution of neuroanatomical phenotypes in the aniridia population as a whole. Overall, this will serve to clarify the extent of abnormalities in five brain structures in persons with aniridia with varied mutations to the *PAX6* gene and contribute to our global understanding of the neuroanatomical characteristics of the disorder.

Methods
=======

Subjects
--------

A total of 14 individuals with aniridia and 15 healthy comparison individuals participated in the current study. Data from two participants with aniridia were excluded from analyses (due to a significant artifact and missing data). One healthy subject was excluded due to an anatomical abnormality, and two others were excluded because they did not match the demographic profile of an individual in the aniridia group included in the analysis. The remaining 12 individuals with aniridia (7 females; 3 left handed; mean age=36 years, SD=15) and 12 age- and gender-matched comparisons (7 females; 4 left handed; mean age=35 years, SD=14) were included in the analyses ( [Table 1](#T1){ref-type="table"}). Healthy comparison subjects were recruited through flyers posted in the community. Participants with aniridia were recruited through the Aniridia Foundation International Conference held in 2011 in Athens, Georgia and had been clinically diagnosed with aniridia. Exonic sequencing of the *PAX6* gene (11p13) (OMIM: 607108) was conducted at the University of Georgia, as previously described ^[@ref-10],\ [@ref-24]^. All mutations, which can be found in [Table 1](#T1){ref-type="table"}, have been submitted to the Human *PAX6* Allelic Variant Database ( <http://lsdb.hgu.mrc.ac.uk/home.php?select_db=PAX6>), as part of a previous genotype identification study ^[@ref-10]^. Three of the participants with aniridia belonged to the same family, and all other participants included in the analyses were unrelated. After written informed consent was obtained and MRI safety screening was conducted, all participants completed an MRI session in which a high-resolution structural scan was obtained. The Institutional Review Board of the University of Georgia approved all activities prior to subject recruitment, data collection, and data analysis (project number: 2011-10862-1; STUDY00003122).

###### ANIRIDIA. Subject demographics and structural abnormalities as seen in structural magnetic resonance images.

Gender, age, handedness, mutation, and structural abnormalities of both aniridia subjects and healthy comparisons. Subject ID: Numbers are matched subjects, A refers to aniridia subjects, C refers to healthy comparisons. ND, not determined.

  --------------------------------------------------------------------------------------------------------------------------------------------------
  ANIRIDIA                                                                                                                                 
  ------------------------------------ -------- ---- -------------- ------------- ------------- --------- ---------- --------- ----------- ---------
  1A                                   Male     18   Right          c.949C\>T     Nonsense      Reduced   Normal     Reduced   Normal      Reduced

  2A                                   Female   19   Ambidextrous   c.771delG     Frameshift\   Reduced   Normal     Reduced   Slightly\   Reduced
                                                                                  deletion                                     reduced     

  3A ^[\*](#tfn1){ref-type="other"}^   Male     20   Right          c.204delC     Frameshift\   Reduced   Normal     Reduced   Normal      Reduced
                                                                                  deletion                                                 

  4A ^[\*](#tfn1){ref-type="other"}^   Female   24   Left           c.204delC     Frameshift\   Reduced   Reduced    Reduced   Normal      Reduced
                                                                                  deletion                                                 

  5A                                   Female   25   Left           ND            ND            Reduced   Reduced\   Highly\   Normal      Reduced
                                                                                                          center     reduced               

  6A                                   Female   28   Right          c.28C\>T      Nonsense      Reduced   Normal     Absent    Slightly\   Normal
                                                                                                                               reduced     

  7A                                   Male     39   Right          c.482delG     Frameshift\   Reduced   Normal     Reduced   Normal      Normal
                                                                                  deletion                                                 

  8A                                   Male     47   Right          ND            ND            Reduced   Normal     Reduced   Normal      Normal

  9A ^[\*](#tfn1){ref-type="other"}^   Male     46   Left           c.204delC     Frameshift\   Reduced   Normal     Reduced   Normal      Reduced
                                                                                  deletion                                                 

  10A                                  Female   51   Right          c.766-3C\>G   Splice\       Reduced   Reduced    Absent    Normal      Normal
                                                                                  junction\                                                
                                                                                  disruption                                               

  11A                                  Female   53   Right          ND            ND            Reduced   Reduced    Reduced   Normal      Normal

  12A                                  Female   60   Ambidextrous   c.799A\>T     Nonsense      Reduced   Reduced    Reduced   Slightly\   Reduced
                                                                                                                               reduced     
  --------------------------------------------------------------------------------------------------------------------------------------------------

\* Indicates individuals from a single family

  -----------------------------------------------------------------------------------------------------
  PAX6 NORMAL                                                                                  
  ------------- -------- ---- ------- --------- ----- --------- --------- ----------- -------- --------
  1C            Male     18   Right   *PAX6*\   N/A   Normal    Normal    Normal      Normal   Normal
                                      Normal                                                   

  2C            Female   20   Right   *PAX6*\   N/A   Normal    Normal    Normal      Normal   Normal
                                      Normal                                                   

  3C            Male     21   Right   *PAX6*\   N/A   Normal    Normal    Slightly\   Normal   Normal
                                      Normal                              Reduced              

  4C            Female   22   Left    *PAX6*\   N/A   Normal    Normal    Normal      Normal   Normal
                                      Normal                                                   

  5C            Female   23   Left    *PAX6*\   N/A   Normal    Normal    Normal      Normal   Normal
                                      Normal                                                   

  6C            Female   28   Left    *PAX6*\   N/A   Normal    Normal    Normal      Normal   Normal
                                      Normal                                                   

  7C            Male     37   Right   *PAX6*\   N/A   Normal    Normal    Normal      Normal   Normal
                                      Normal                                                   

  8C            Male     50   Right   *PAX6*\   N/A   Normal    Normal    Normal      Normal   Normal
                                      Normal                                                   

  9C            Male     50   Left    *PAX6*\   N/A   Reduced   Normal    Normal      Normal   Normal
                                      Normal                                                   

  10C           Female   48   Right   *PAX6*\   N/A   Reduced   Reduced   Absent      Normal   Normal
                                      Normal                                                   

  11C           Female   51   Right   *PAX6*\   N/A   Normal    Normal    Reduced     Normal   Normal
                                      Normal                                                   

  12C           Female   56   Right   *PAX6*\   N/A   Normal    Normal    Reduced     Normal   Normal
                                      Normal                                                   
  -----------------------------------------------------------------------------------------------------

MRI data acquisition
--------------------

All data were collected on a 3T GE Signa MRI (General Electric, Milwaukee, WI, USA) at the University of Georgia's Bio-Imaging Research Center. To obtain a high-resolution structural scan, images were acquired with a T1-weighted 3D FSPGR sequence \[echo time (TE)=min full, flip angle=20°; field of view (FOV)=240 mm × 240 mm; matrix size=256 × 256, 150 axial slices; in-slice resolution=0.94 × 0.94 mm; slice thickness=1.2 mm\].

MRI structural analysis
-----------------------

MR images were transferred to a DICOM image format and analyzed using two software programs, SPM run on MATLAB and OsiriX. For SPM analysis, DICOM files were converted to nifti format and analyzed using Statistical Parametric Mapping Software (SPM8; Wellcome Trust Centre for Neuroimaging; <http://www.fil.ion.ucl.ac.uk/spm/>) run on a MATLAB software platform (MATLAB Release 2015b; The Mathworks, Inc., Natick, MA, USA). SPM software was used to compare aniridia subjects to their demographically matched comparison subjects. DICOM files were additionally analyzed using Osirix Lite DICOM viewer (OsiriX v5.6,;Pixmeo SARL, Bernex, Switzerland) and all images generated using this software. All 24 individual subjects' data were visually inspected for gross anatomical abnormalities in two independent sessions by the first author (MG) and a radiologist (JDW). Regions of interest were determined by literature review to include the anterior commissure, posterior commissure, pineal gland, corpus callosum, and optic chiasm. The only structure that has been examined in the literature that we did not examine in our population was the olfactory bulb. This structure was excluded because both evaluators independently determined that the olfactory bulb could not be reliably assessed in the current data set. The radiologist was blinded to patient status and genotype during visual examination of scans. No new regions of interest were determined during both the first and second examination of the scans.

Corpus callosum quantitative analysis
-------------------------------------

Following the approach of Free and colleagues (2003), the cross-sectional area of the corpus callosum was quantified at the mid-sagittal plane ^[@ref-21]^. In order to align all MR images to the mid-sagittal plane, individual T1 images were reconstructed in AFNI software ^[@ref-25]^ and aligned manually using the anterior commissure, posterior commissure, and interhemispheric landmarks. On the mid-sagittal image, the corpus callosum was manually traced and the number of voxels within this delineation was counted. Additionally, the structural volumes were automatically segmented with FreeSurfer software ( <http://surfer.nmr.mgh.harvard.edu>) to obtain estimates of total grey and white matter volume ^[@ref-26],\ [@ref-27]^. The ratio of corpus callosum area to total cerebral volume was calculated to control for differences in overall brain size (see [Supplementary Figure 1](#SF1){ref-type="other"} "Ratio"). [Supplementary Figure 1](#SF1){ref-type="other"} graphs were created using GraphPad Prism 7 software ( <https://www.graphpad.com/>).

Results
=======

Whole brain analysis was used to identify major structural abnormalities in aniridia patients. All neuroanatomical results are reported in [Table 1](#T1){ref-type="table"}, which includes subject demographics and mutations. We analyzed five major brain structures that demonstrate clear anatomical abnormalities in aniridia patients. Our study showed that all 12 aniridia patients had a reduced anterior commissure when compared to their demographically matched healthy comparisons, as shown in [Figure 1](#f1){ref-type="fig"}. The posterior commissure was reduced in 5/12 aniridia patients and normal in 7/12 of aniridia patients ( [Figure 1](#f1){ref-type="fig"}). Of the five aniridia patients with reduced posterior commissures, one had a reduced commissure at the midline. The pineal gland was affected in all 12 aniridia patients: absent in two ( [Figure 1](#f1){ref-type="fig"}), highly reduced in one, and reduced in nine. The corpus callosum was slightly thinned in 3/12 aniridia patients and normal in 9/12 aniridia patients ( [Figure 2](#f2){ref-type="fig"}). The optic chiasm was reduced in 7/12 of patients ( [Figure 2](#f2){ref-type="fig"}) and normal in 5/12 patients.

![Anterior commissure, posterior commissure, and pineal gland:\
Axial cerebral T1-weighted magnetic resonance images, slice thickness 1.2mm. ( **A**) Subject 6C: Arrow shows normal anterior commissure; arrowhead shows normal posterior commissure; dashed arrow shows normal pineal gland. ( **B**) Subject 6A: Arrow shows reduced anterior commissure; arrowhead shows normal posterior commissure; dashed arrow shows absence of pineal gland.](f1000research-6-13553-g0000){#f1}

![Optic chiasm and corpus callosum:\
Coronal cerebral T1-weighted magnetic resonance images, slice thickness 1.2mm. ( **A**) Subject 2C: Arrow shows normal optic chiasm. ( **B**) Subject 2A: Arrow shows reduced optic chiasm. Arrowheads in **A** and **B** denote normal corpus callosum.](f1000research-6-13553-g0001){#f2}

In an effort to consider normal structural variation in the healthy population, we also evaluated healthy comparisons for structural brain abnormalities. We saw a reduced anterior commissure in two of the healthy comparisons and a reduced posterior commissure in one healthy comparison. The pineal gland showed the most variance within the healthy comparison group with one subject with no visible pineal gland, three healthy comparisons with slightly reduced to reduced pineal glands, and eight healthy comparisons with normal pineal glands. All healthy comparisons had normal corpus callosums and optic chiasms. A full description of which structures showed abnormalities in both the aniridia and healthy comparison groups are reported in [Table 1](#T1){ref-type="table"}. These findings provide context for asserting disease-related changes in the aniridia population, in the current study as well as others.

Additionally, we examined corpus callosum area at the mid-sagittal plane along with grey matter, white matter, and whole brain volume in our aniridia and healthy comparison groups. Grey matter volume and total brain volume averages are indistinguishable between aniridia and healthy comparison subjects. There is a slight reduction in the aniridia patients compared to healthy individuals in average corpus callosum area as well as white matter volume and ratio of corpus callosum area to whole brain volume. However, these are just trends and no measurement was statistically significant, which can also be explained by a high degree of variability within the aniridia population. Volumetric and area measurements along with graphical representations of the data can be seen in [Supplementary Table 1](#ST1){ref-type="other"} and [Supplementary Figure 1](#SF1){ref-type="other"}.

###### 

Structural MRI DICOM files for 12 aniridia and 12 healthy comparison individuals. Files are in DICOM format and labeled according to subject I.D. found in [Table 1](#T1){ref-type="table"}. These files can be opened using SPM software run in Matlab or OsiriX DICOM viewer (see Methods section).

###### 

Click here for additional data file.
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Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication).

Discussion
==========

The most commonly reported neuroanatomical abnormality in MRI studies of aniridia patients is the anterior commissure. Previous studies have reported changes in the anterior commissure with some cases described as reductions and others reported as complete absence of the structure ^[@ref-9],\ [@ref-17]--\ [@ref-19]^. Consistent with these reports, our study identified a reduction in the anterior commissure in all 12 aniridia patients, but none of the patients lacked the structure. The posterior commissure has also been evaluated in previous studies: one study reports that it is present in all subjects while the other study presented evidence that one patient had an absent structure while the others had normal posterior commissures ^[@ref-18],\ [@ref-20]^. We found no individuals lacking the posterior commissure, and fewer than half of our aniridia patients seemed to have an abnormal structure. Interestingly though, it seems as if one patient exhibited a reduction of the posterior commissure at the midline with thickened bundles adjacent to the midline suggesting that commissure formation was incomplete. PAX6 has a known role in formation of the posterior commissure in rodents, so it is likely that this phenotype in humans is a direct consequence of PAX6 deficiency ^[@ref-15]^. In agreement with previous findings, we also see abnormal or absent pineal glands in our entire patient population. This finding is consistent with sleep regulation deficits in persons with aniridia reported in other studies ^[@ref-28]^. The corpus callosum has also been a structure commonly evaluated in aniridia MRI studies, with many reporting reductions in corpus callosum thickness and severe agenesis ^[@ref-9],\ [@ref-19],\ [@ref-20]^. However, we found very few patients present with a reduced or abnormal corpus callosum, and propose that the slight reduction we see in three of our patients falls within normal population variation. Unlike most previous studies, we examined the optic chiasm, and found a reduction in the structure in more than half of our patients. This reduction could be a developmental consequence of the disorder or a progressive phenotype associated with reduced levels of PAX6. Anatomical abnormality findings seem to be highly dependent on population sample, and a larger collective sample in the literature will help us get closer to understanding common disease traits and variation.

As described above, we observed a reduction in the anterior commissure in every patient we evaluated and a reduction of the posterior commissure in five patients, but no individuals completely lacked either structure. Our study utilized a high resolution 3T MRI for data acquisition, while most other studies used a 1.5T MRI. Signal to noise ratio from 3T MRIs are almost double that of 1.5T MRIs, which will lead to an improved image quality and resolution from the 3T magnet ^[@ref-29]^. We propose that the difference in observing a reduced versus absent anterior/posterior commissure may be due to a difference in scan resolution between images captured from a 3T versus 1.5T magnet. We see multiple patients in our group who have a severely reduced anterior commissure, and identifying this abnormality using a 1.5T magnet may be more difficult than when using a 3T. Additionally, the posterior commissure is smaller than the anterior commissure naturally, making it more difficult to distinguish between presence and absence in a scan. Lower scan resolution may not capture small structures such as these commissures, especially if they are reduced in size, leading to a false judgment of their absence.

A recent study has found an age component to cortical thickness in aniridia patients when compared to healthy individuals. The study found that in patients with aniridia there is an accelerated reduction in cortical thickness of the inferior parietal lobe and prefrontal/premotor areas in both brain hemispheres ^[@ref-23]^. Adding to this age component seen in the Yogarajah (2016) study, there are also population differences in brain anatomy, even within healthy groups, between younger subjects and older subjects ^[@ref-30]^. Additionally, as we show in our study, there are anatomical abnormalities even within healthy, unaffected participants. This makes it vitally important for careful selection of comparison subjects, and presents a caveat for interpreting differences we see in this and other clinical populations.

In addition to abnormal structural findings in patient populations with aniridia, multiple studies have assessed volumetric differences in grey and white matter in the brains of aniridia versus healthy comparisons. Similar to the findings in gross structural differences, much variation exists between reports. Some studies show an increase in grey matter volume in aniridia patients compared to healthy control groups, while others find both increases and decreases depending on brain region ^[@ref-21],\ [@ref-22]^. Changes in white matter findings follow the same suit with some reports of reductions in white matter and others finding both reductions and increases ^[@ref-21],\ [@ref-22]^. Even more interestingly, structures, such as the anterior commissure, posterior commissure, and pineal gland, show no deviation from healthy in these group-wise comparisons. This suggests that either the abnormalities seen in these structures are not as common among aniridia patients as previously thought, or that the characteristics of anatomical changes observed in aniridia patients have a high degree of variability within the population. Due to the consistency of abnormalities in structures like the anterior commissure in our study, as well as others, we predict the latter explains this discrepancy. This explanation is supported by the consistency of our results from volumetric and visual inspection of the corpus callosum in the current dataset. It is also possible that the differences observed across and within studies of these structures are a result of scan resolution and inconsistency of structure localization or plane of imaging to capture them given their small size and overall individual anatomical variation.

Conclusions
===========

The current study investigated anatomical brain abnormalities correlated to aniridia in a new population sample in an effort to serve as a comparison to previous studies. Our aim was to contribute to what is known about the distribution of neuroanatomical phenotypes in the aniridia population as a whole. Although we found similar neuroanatomical abnormalities as previous studies, we find the severity is not as great as previously reported. The anterior commissure and pineal gland seem to be the structures most affected in the aniridia patients we examined, and we do see abnormalities in the posterior commissure, corpus callosum and the optic chiasm, albeit at lower frequency than previously reported. We believe the neuroanatomical abnormalities seen in aniridia populations have a high level of variability, and future studies should be aimed at collecting more patient MRI scans so that the breadth of abnormalities can be assessed.

Ethical approval and consent
============================

MRI sessions were completed after written informed consent was obtained and MRI safety screening was completed. All activities were approved by the Institutional Review Board of the University of Georgia prior to subject recruitment and data collection. All individuals who participated in this study provided consent for their demographic, mutation information, and images to be published.

Data availability
=================

The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2017 Grant MK et al.

Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication). <http://creativecommons.org/publicdomain/zero/1.0/>

**Dataset 1: Aniridia and healthy comparison MRI data:** Structural MRI DICOM files for 12 aniridia and 12 healthy comparison individuals. Files are in DICOM format and labeled according to subject I.D. found in [Table 1](#T1){ref-type="table"}. These files can be opened using SPM software run in Matlab or OsiriX DICOM viewer (see Methods section). doi, [10.5256/f1000research.11063.d153799](http://dx.doi.org/10.5256/f1000research.11063.d153799) ^[@ref-31]^

Mutation information that has been presented here is also available through *PAX6* Allelic Variant Database ( <http://lsdb.hgu.mrc.ac.uk/home.php?select_db=PAX6>).

AMB is a Franklin Foundation Neuroimaging Fellow and an ARCS Scholar.

Collection of magnetic resonance imaging data was made possible by the University of Georgia Bioimaging Research Center. J. Branson Byers participated as an undergraduate researcher through the Center for Undergraduate Research Opportunities at the University of Georgia. The authors wish to thank Ms. Kimberly Mason for her assistance with data collection and subject screening, Ms. Jill Nerby, Director and Founder of Aniridia Foundation International, and the participants in this study for their support of this research.

Supplementary Material {#S01}
======================

###### Subject corpus callosum area and brain volume measurements.

Grey matter volume, white matter volume, total brain volume, and corpus callosum area of aniridia and matched subjects. Ratio refers to corpus callosum area/total brain volume. Subject ID: Numbers are matched subjects, A refers to aniridia subjects, C refers to healthy comparisons.

  ANIRIDIA                                                               
  ------------------------------------ -------- -------- --------- ----- ----------
  1A                                   795957   654158   1450115   774   0.000534
  2A                                   711626   604800   1316426   552   0.000419
  3A ^[\*](#tfn2){ref-type="other"}^   683393   585559   1268952   712   0.000561
  4A ^[\*](#tfn2){ref-type="other"}^   568045   505360   1073405   584   0.000544
  5A                                   595209   573664   1168873   648   0.000554
  6A                                   543481   496139   1039620   542   0.000521
  7A                                   602438   545307   1147745   566   0.000493
  8A                                   646003   616039   1262042   732   0.00058
  9A ^[\*](#tfn2){ref-type="other"}^   621706   607971   1229677   684   0.000556
  10A                                  533370   495092   1028462   713   0.000693
  11A                                  623640   592662   1216302   652   0.000536
  12A                                  528675   489748   1018423   555   0.000545

\* Indicates individuals from a single family

  PAX6 NORMAL                                     
  ------------- -------- -------- --------- ----- ----------
  1C            653601   568784   1222385   685   0.00056
  2C            600216   547621   1147837   653   0.000569
  3C            710079   668109   1378188   657   0.000477
  4C            611409   542922   1154331   643   0.000557
  5C            605760   545683   1151443   883   0.000767
  6C            626978   587857   1214835   963   0.000793
  7C            728278   734113   1462391   667   0.000456
  8C            632857   647710   1280567   721   0.000563
  9C            595440   613750   1209190   477   0.000394
  10C           523144   484070   1007214   618   0.000614
  11C           667226   616716   1283942   795   0.000619
  12C           525662   540868   1066530   856   0.000803

###### Subject ID.

Subject ID used in this paper, MRI DICOM ID for DICOM file matching, and Person ID from *Bobilev et al. 2016* ^[@ref-10]^.

  --------------------------------------------
  Subject\   MRI DICOM\    *Bobilev et al.*\
  ID         ID            *2016* Person ID
  ---------- ------------- -------------------
  1A         50009         1001A316/sUGA

  2A         50005         124A141/s-124

  3A         50022         147A061/f-149

  4A         50013         147A064/f-148

  5A         50014         N/A

  6A         50036         157A121/s-157

  7A         50003         114A159/f-173

  8A         50010         N/A

  9A         50012         147A017/f-147

  10A        50015         173A291/s-220

  11A        50011         N/A

  12A        50016         191A297/s-222

  1C         1002          N/A

  2C         50031         N/A

  3C         1003          N/A

  4C         50028         N/A

  5C         50044         N/A

  6C         50037         N/A

  7C         50003 Match   N/A

  8C         50034         N/A

  9C         1017          N/A

  10C        1070          N/A

  11C        50032         N/A

  12C        50064         N/A
  --------------------------------------------

**Supplementary Figure 1: Corpus Callosum Cross-sectional area and brain volume comparisons.** ( **A**) Representation of manually traced corpus callosum in a mid-sagittal slice. ( **B**) Corpus callosum area. ( **C**) Grey matter volume. ( **D**) White matter volume. ( **E**) Total brain volume. ( **F**) Ratio of corpus callosum area to total brain volume. Line in each graph represents average of group. No statistically significant differences were observed for any of the measurements depicted in this figure (p \< 0.05).

Click here for additional data file.
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Version 1

This is an interesting and extremely important study reporting specific neuroanatomical features in patient group suffering from a rare disease affecting the visual system: aniridia. I have listed my comments and suggestions below.

[Introduction]{.ul}

The introduction is fine and discusses the current literature. However, I would suggest to improve a bit the study question. The study question as it is used in the current version is very broad and does not come to the point (e.g.,\"The current study sought to investigate gross anatomical correlates of aniridia in a new population sample. Results from this study will serve as a comparison for previous studies, as well as contribute to what is known about the distribution of neuroanatomical phenotypes in the aniridia population as a whole.\"). I would suggest to include a few statements what this new study will add to the literature and what the \"problems\" of the older studies are? In addition, it could be helpful for the reader to learn the very new and maybe innovative aspects of this study.

[Methods]{.ul}

Subjects: Some additional information about the subjects could be helpful (cognitive ability, handedness, language lateralization). Some of these variables have been shown to be strongly related to the anatomical measures for which the authors are reporting the specific aniridia features.

Statistics: It is not entirely clear how the authors did their between-group comparisons. Did they compare the patients only on a visual-descriptive basis or did they perform a statistical analysis (which I would suggest). When doing a statistical analysis, one could compare single subjects to the mean of the control group. Thus, it would be possible to test each patient against the mean of the healthy control group. Using this comparison it would also be possible to calculate effect size measures for each subject.

By the way, did the use a priorly defined regions of interest?

[Discussion]{.ul}

The discussion is fine.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Grant

Madison

University of Georgia, USA

**Competing interests:**No competing interests were disclosed.
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**Dr. Lutz Jäncke**, Department of Psychology (Neuropsychology) and INAPIC, University of Zurich, Zurich, Switzerland 

We thank Dr. Jäncke for the helpful comments and suggestions, which improved the manuscript. Our responses are listed below.

[Introduction]{.ul} Improve study question  Introduction has been revised to improve, clarify, and expand the description of our study question.Suggest: to include a few statements what this new study will add to the literature and what the \"problems\" of the older studies are? In addition, it could be helpful for the reader to learn the very new and maybe innovative aspects of this study.  Introduction has been revised to include more information on new aspects for this study. In particular we have emphasized at the end of the " *Introduction*" section that this study utilized a 3T magnet instead of a 1.5T, allowing for higher resolution when examining small structures such as the anterior and posterior commissure.  Additionally, we also clarified, at the end of the " *Introduction*" section, that our study examined five structures shown to be abnormal in the aniridia population. Previous studies focused on only a subset of structures in each patient rather than all five.  By examining all five structures in a new population of aniridia patients, we have added to the collective knowledge on structural brain abnormalities present within the disorder.  

[Methods]{.ul} Subjects: additional information: cognitive ability, handedness, language lateralization  We added handedness and predicted protein effect to Table 1. We do not have data on cognitive ability or language lateralization for our participants.Statistics: It is not entirely clear how the authors did their between-group comparisons. Did they compare the patients only on a visual-descriptive basis or did they perform a statistical analysis (which I would suggest). When doing a statistical analysis, one could compare single subjects to the mean of the control group. Thus, it would be possible to test each patient against the mean of the healthy control group. Using this comparison it would also be possible to calculate effect size measures for each subject.  For this study, the structural changes in Table 1 were concluded by two independent reviews of the MRI scans using a visual-descriptive basis.  The methods have been updated to clarify the visual-descriptive assessment. Volumetric analysis was conducted for the corpus callosum using Freesurfer software and results have been added to the manuscript (see supplementary Table 1 and supplementary Figure 1). Findings from this volumetric analysis confirmed our structural examination of the corpus callosum for all subjects.  We did not conduct quantitative volumetric analyses on the anterior and posterior commissures as these are relatively small structures and the plane of view was not consistent within all subjects. This is due to variation in slice location within each brain. Because of this we decided to rely on our visual-descriptive assessment of these two structures for our dataset. While not ideal, a visual-descriptive assessment of the anterior and posterior commissures is consistent with previous reports comparing these structures between PAX6 normal individuals and individuals with PAX6 mutations (e.g. Sisodiya et al. 2001; Abouzeid et al., 2009) and captures relative changes between these two groups.By the way, did the use a priorly defined regions of interest?  Yes, our Methods section (MRI data analysis) has been revised to state how we determined regions of interest.  We used literature review to define which structures would be examined, and had ourthe radiologist (JD) examined the MRI scans  for identification of additional regions of interest. [Discussion]{.ul}

The discussion is fine.

Jäncke
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Psychology Division Neuropsychology, University of Zurich, Switzerland

**Competing interests:**No competing interests were disclosed.
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Thank you so much. Well done!
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Version 1

This is an interesting report on structural brain changes in 12 aniridia patients examined by structural MRI studies, using 12 selected matching controls for comparison. The title and abstract convey details appropriately.

I should say at the outset that I have no expertise in MRI methodology and cannot compare the techniques used here with those used elsewhere, including our own papers.

It is clear, however, that MRI has advanced technically to a significant extent since the first set of papers was published in 2001-3. We need to know how directly comparable the results are. Certainly Sisodiya et al. in 2001 (ref 17) Mitchell et al. and 2003 (ref 18) used voxel-based morphometry and less powerful MRI measurements but showed similar findings with observed reduction or absence of the anterior commissure and olfactory bulb (ref 17) and of the pineal (ref 18). The current study does not mention study of the olfactory bulb. Interestingly olfactory function was also shown to be reduced and very occasionally absent in the first study (ref 17). Reduced interhemispheric transfer is thought to underlie the observed auditory processing problems reported in children with aniridia in ref 19. The current study reported in this paper does not undertake functional smell or auditory tests. Although what seems to be the same cohort, judging by the reported mutations, has been studied by functional fMRI by Pierce et al (ref 24). Surprisingly this overlapping author group (with the current paper) reports an apparently increased functional connectivity in the patients studied in the current paper. The earlier studies by other groups do not look at these functional connectivity changes. It is regrettable that the later studies, including Yogarajah et al (ref 23) did not follow this up.

Otherwise the major findings are remarkably similar for this study and the previous studies to explore 12 or more cases. The controls in ref 17 and 18 are larger numbers (100) and not directly paired controls. The study in Ref 20 where the posterior commissure reduction was observed, only looked at the index case from three families with aniridia and PAX6 mutations. Reference 23 re-examines many of the same cases as Ref 17 and 18, but about a decade later and with more powerful MRI using surface-based morphometry. The reduced cortical measurements are more obvious in these older cases. The observed reduction of the optic chiasm reported here  in 7/12 cases is an interesting new finding, first suggested in the one of the three families studied by Abouzeid et al, ref 20.

Minor comments In the Introduction the PAX6 mutations are described as mostly "single nucleotide polymorphisms". This is incorrect the changes are extremely rare variants. There are no polymorphisms of any note in the extremely highly conserved PAX6 gene.It is a pity that the patient numbering is different in earlier fMRI work from this group (ref 24). Indeed it is not made clear that ref 24 studies the same cohort as observed in the current paper.It would help to have the protein effects of the mutations in Table 1.Can the olfactory bulb status be observed with the current cohort? It would be interesting to see that reported.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Grant

Madison

University of Georgia, USA

**Competing interests:**No competing interests were disclosed.
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**Reviewer: Veronica van Heyningen**, Institute of Ophthalmology, University College London, London, UK 

We thank Dr. van Heyningen for the helpful comments and suggestions, which improved the manuscript. Our responses are listed below.

Comments to the Author:

Minor comments In the Introduction the PAX6 mutations are described as mostly "single nucleotide polymorphisms". This is incorrect the changes are extremely rare variants. There are no polymorphisms of any note in the extremely highly conserved PAX6 gene.- The text was modified to read: "The majority of these variants are nonsense mutations, which lead to a premature termination codon, and are found across the *PAX6* locus."It is a pity that the patient numbering is different in earlier fMRI work from this group (ref 24). Indeed it is not made clear that ref 24 studies the same cohort as observed in the current paper.- Numbering of patients has been amended to reflect the same numbering used in the previous paper (ref 24).  We have additionally added a supplementary table (Supplementary Table 2) that matches DICOM file names to patient ID from this paper and previous papers using the same patient group.  Additionally, we have added a sentence in methods (Subjects) to state that this study and ref 24 used the same patients.It would help to have the protein effects of the mutations in Table 1.- Protein effects have been added to Table 1.Can the olfactory bulb status be observed with the current cohort? It would be interesting to see that reported.- While we agree that the olfactory bulb would be an interesting and important addition, we elected not to pursue this structure because constraints inherent to our data.  We have amended methods (MRI data analysis) to discuss explain why we decided not to investigate olfactory bulb in this patient sample.

[^1]: AMB and JDL conceived this study as part of a large neuroimaging effort in this clinical population. JEP provided technical expertise on MRI imaging and data acquisition, and assisted AMB with experimental design and data collection. MKG analyzed the data first followed by JDW, who analyzed the data second (independently) to determine structural abnormalities in each brain. MKG and AMB prepared the first draft of the manuscript. All authors were involved in the revisions of the draft manuscript and have agreed to the final content.

[^2]: **Competing interests:**No competing interests were disclosed.
